Compare TGHL & MBAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TGHL | MBAI |
|---|---|---|
| Founded | 2020 | 2004 |
| Country | Singapore | Israel |
| Employees | N/A | 85 |
| Industry | EDP Services | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.5M | 12.0M |
| IPO Year | N/A | N/A |
| Metric | TGHL | MBAI |
|---|---|---|
| Price | $0.31 | $1.56 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 21.1K | ★ 46.8K |
| Earning Date | 05-18-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.29 | $1.31 |
| 52 Week High | $3.80 | $3.92 |
| Indicator | TGHL | MBAI |
|---|---|---|
| Relative Strength Index (RSI) | 39.74 | 42.42 |
| Support Level | $0.29 | $1.44 |
| Resistance Level | $0.51 | $1.83 |
| Average True Range (ATR) | 0.03 | 0.12 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 10.81 | 19.45 |
The Growhub Ltd operates at the intersection of technology and supply chain management in the food industry, focusing on enhancing product traceability and authenticity. With a commitment to innovation and sustainability, It has developed a multi-faceted approach to address industry challenges. its business currently comprises two main divisions, which are the GrowHub Platform and its product trading facilitation offering.
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.